Neurovascular and neuroimaging effects of the hallucinogenic serotonin receptor agonist psilocin in the rat brain
Spain Aisling, Howarth Clare, Khrapitchev Alexandre A., Sharp Trevor, Sibson Nicola R., Martin Chris
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (65)
- Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. 2015-01-15 · Expand citations
- Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. 2012-03-01 · Expand citations
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. 2012-02-07 · Expand citations
- Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. 2012-02-01 · Expand citations
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. 2011-09-01 · Expand citations
- Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
- The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. 2010-09-01 · Expand citations
- The pharmacology of psilocybin. 2002-10-01 · Expand citations
- Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG. 1999-06-01 · Expand citations
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. 1998-12-01 · Expand citations
- Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man 1997-06-01 · Expand citations
- Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis. 1997-05-01 · Expand citations
- A possible correlation between drug-induced hallucinations in man and a behavioural response in mice. 1966-12-30 · Expand citations
- 10.1002/jmri.20584
- 10.1002/jmri.23914
- 10.1002/nbm.1940070106
- 10.1007/bf01062336
- 10.1007/s00213-014-3855-0
- 10.1007/s12035-011-8214-0
- 10.1016/0163-7258(94)90048-5
- 10.1016/j.dcn.2013.07.003
- 10.1016/j.ejphar.2012.05.031
- 10.1016/j.neubiorev.2013.07.018
- 10.1016/j.neuroimage.2004.08.011
- 10.1016/j.neuroimage.2004.12.010
- 10.1016/j.neuroimage.2005.08.028
- 10.1016/j.neuroimage.2006.02.021
- 10.1016/j.neuroimage.2006.11.010
- 10.1016/j.neuroimage.2009.06.021
- 10.1016/j.neuroimage.2009.10.013
- 10.1016/j.neuroimage.2010.03.060
- 10.1016/j.neuroimage.2011.09.015
- 10.1016/j.neuroimage.2012.01.040
- 10.1016/j.neuroimage.2012.10.006
- 10.1016/j.neuroimage.2013.02.046
- 10.1016/j.neuroimage.2013.03.002
- 10.1016/j.neuron.2007.11.008
- 10.1016/j.neuropharm.2008.08.014
- 10.1016/j.neuropharm.2011.01.015
- 10.1016/j.neuroscience.2009.10.006
- 10.1016/j.pharmthera.2010.06.005
- 10.1016/s0006-8993(01)03121-3
- 10.1016/s0165-0270(03)00192-4
- 10.1016/s0301-0082(96)00033-0
- 10.1017/s1461145714000261
- 10.1038/jcbfm.1992.127
- 10.1038/jcbfm.2012.23
- 10.1038/nature06976
- 10.1038/nn1675
- 10.1038/nrd2027
- 10.1046/j.1468-2982.2002.00395.x
- 10.1073/pnas.0407789102
- 10.1093/schbul/sbt086
- 10.1097/00004647-200208000-00002
- 10.1111/ejn.12024
- 10.1111/j.1460-9568.2009.06812.x
- 10.1126/science.1110948
- 10.1152/japplphysiol.00954.2005
- 10.1177/0269881110372547
- 10.1371/journal.pone.0009019
- 10.1523/jneurosci.3065-04.2004
- 10.1523/jneurosci.3346-12.2013
- 10.1523/jneurosci.3447-08.2009
- 10.1523/jneurosci.5015-08.2009
- 10.1523/jneurosci.6063-09.2010